Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebrolysin on Prolonged Disorders of Consciousness in Hemorrhagic Stroke
NCT04427241Phase 4Recruiting
- Sponsor
- Konkuk University Medical Center
- Start
- Jun 2023
- Primary completion
- Sep 2026
- Modality
- Native Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of cerebrolysin in disorder of consciousness (DOC) (2 arms), sponsored by Konkuk University Medical Center. Primary endpoints: Coma Recovery Scale - revised at 17 days and Positron Emitting Tomography at 17 days. Started Jun 2023; status: recruiting.
02
Drugs
cerebrolysin
03
Conditions
disorder of consciousness (DOC)
Beyond the preview
Go deeper on NCT04427241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04427241.